About the Authors
- Polina Rabinovich-Toidman
-
Affiliation Department of Molecular Microbiology & Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University,Tel-Aviv, Israel
- Inna Rabinovich-Nikitin
-
Affiliation Department of Molecular Microbiology & Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University,Tel-Aviv, Israel
- Assaf Ezra
-
Affiliation Department of Molecular Microbiology & Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University,Tel-Aviv, Israel
- Beka Barbiro
-
Affiliation Department of Molecular Microbiology & Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University,Tel-Aviv, Israel
- Hilla Fogel
-
Affiliation Department of Physiology and Pharmacology, Sackler Faculty of Medicine; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel
- Inna Slutsky
-
Affiliation Department of Physiology and Pharmacology, Sackler Faculty of Medicine; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel
- Beka Solomon
-
* E-mail: beka@post.tau.ac.il
Affiliation Department of Molecular Microbiology & Biotechnology, George S. Wise Faculty of Life Sciences, Tel-Aviv University,Tel-Aviv, Israel
Competing Interests
The therapeutic approach described here is under a patent application (Methods and compositions with immune therapy for treatment of Dementia. PCT/US2014/26377). None of the authors hold any equity in NasVax Ltd, Israel. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: BS IS. Performed the experiments: PRT IRN AE BB HF. Analyzed the data: PRT IRN AE BB HF. Wrote the paper: PRT BS IS.